SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-028468
Filing Date
2021-02-25
Accepted
2021-02-25 21:24:16
Documents
1
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm217951d2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm217951d2_3seq1.xml 3 3263
  Complete submission text file 0001104659-21-028468.txt   4606
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Issuer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks
Office of Real Estate & Construction

Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address
Johnson Calvin B. (Reporting) CIK: 0001840073 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40119 | Film No.: 21683340